ARTICLE | Company News
Amunix, Biogen Idec deal
April 28, 2014 7:00 AM UTC
Amunix said that Biogen Idec exercised its option under a 2011 deal to gain exclusive, worldwide rights to develop and commercialize Factor VIII products using Amunix's recombinant XTEN technology to ...